13548 Federal Register / Vol. 66, No. 44 / Tuesday, March 6, 2001 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Poison Control Stabilization and

Enhancement Grant Program

AGENCY: Health Resources and Services

Administration, HHS.

ACTION: Notice of availability of funds.

SUMMARY: The Health Resources and

Services Administration (HRSA)

announces that up to $15 million in

fiscal year (FY) 2001 funds is

anticipated for up to 80 grants to

regional poison control centers (PCCs)

for the implementation of project grants

to enhance and improve poison

education, prevention and treatment

services. Grants will be made in the

following categories: financial

stabilization grants to certified PCCs

across the Nation; certification grants to

non-certified PCCs; incentive grants to

encourage collaboration; and system

development and service access grants

for rural and geographically isolated

areas to allow time to obtain certified

poison control services. All awards will

be made under the program authority of

the Poison Center Enhancement and

Awareness Act (Pub. L. 106–174). This

Poison Control Stabilization and

Enhancement Grant Program (CFDA

#93.253) will be administered by the

Maternal and Child Health Bureau

(MCHB), HRSA. Projects in the

following four categories will be

approved for up to a 3-year period, with

awards in subsequent years contingent

upon the availability of funds: (1)

Stabilization grant awards will range

from approximately $60,000 to

$1,600,000 annually, depending on the

size of the population served, and will

be awarded for up to three years; (2)

Certification grants, also population

based, will range from $50,000 to

$200,000 annually and will be awarded

for up to three years; (3) Incentive grants

will be awarded at $125,000 annually

for up to two years; and (4) Service

Access grant awards will be $50,000 for

one year only. Funding for Poison

Control Stabilization and Enhancement

Grants in FY 2001 is made available

under the FY 2001 Labor-HHSEducation Appropriations Act (Pub. L.

106–554).

DATES: The deadline for receipt of

applications is May 8, 2001.

Applications will be considered ‘‘on

time’’ if they are either received on or

before the deadline date or postmarked

on or before the deadline date. The

projected award date is September 1,

2001.

ADDRESSES: To receive a complete

application kit, applicants may

telephone the HRSA Grants Application

Center at 1–877–477–2123 (1–877–

HRSA–123) beginning March 12, 2001,

or register on-line at: http://

www.hrsa.dhhs.gov/, or by accessing

http://www.hrsa.gov/glorder3.htm

directly. This program uses the standard

Form PHS 5161–1 (rev. 7/00) for

applications (approved under OMB No.

0920–0428). Applicants must use

Catalog of Federal Domestic Assistance

(CFDA) number 93.253 when requesting

application materials. The CFDA is a

Government wide compendium of

enumerated Federal programs, projects,

services, and activities which provide

assistance. All applications should be

mailed or delivered to: Grants

Management Officer, MCHB; HRSA

Grants Application Center, 1815 N. Fort

Meyer Drive, Suite 300, Arlington,

Virginia 22209; telephone: 1–877–477–

2123; E-mail: hrsagac @ hrsa.gov.

This application guidance and the

required forms for the Poison Control

Center Stabilization and Enhancement

Grant Program may be downloaded in

either WordPerfect 6.1 or Adobe

Acrobat format (.pdf) from the MCHB

Home Page at http://

www.mchb.hrsa.gov/. Please contact

Joni Johns, at 301/443–2088, or

jjohns@hrsa.gov/, if you need technical

assistance in accessing the MCHB Home

Page via the Internet.

This announcement will appear in the

Federal Register and on the HRSA

Home Page at: http://

www.hrsa.dhhs.gov/. Federal Register

notices are found on the World Wide

Web by following instructions at: http:/

/www.access.gpo.gov/suldocs/aces/

aces140.html.

FOR FURTHER INFORMATION CONTACT:

Carol A. Delany, 301/443–5372, email:

cdelany@hrsa.gov/ (for questions

specific to project activities of the

program, program objectives); Theda

Duvall, 301/443–1440, email

tduvall@hrsa.gov/ (for grants policy,

budgetary, and business questions).

SUPPLEMENTARY INFORMATION:

Program Background and Objectives

Of an estimated four million

poisonings in the United States each

year, more than two million are reported

to PCCs. More than 90 percent of these

poisonings occur in the home and 60

percent of the poisoning victims are

children under age six. United States

PCCs provide easy access, free of charge,

to persons seeking help, including a

telephone hotline staffed by toxicology

professionals and immediate

information and treatment advice

regarding suspected toxic exposures to

drugs, chemicals, plants, and other

substances.

The ready accessibility of high quality

poison control services has been proven

to decrease the severity of illness,

prevent deaths and significantly reduce

health care costs. Despite the life-saving,

cost-effective contributions of poison

control centers to the health and wellbeing of the U.S. population, chronic

underfunding has reduced the number

of centers significantly in the past three

decades. At the present time, funding

instability continues to threaten the

existence of the poison control centers

which serve this country. Unstable

funding has also had an adverse impact

on the capacity of the PCCs to enhance

and improve services and develop a

comprehensive National system.

Public Law 106–174, the ‘‘Poison

Control Center Enhancement and

Awareness Act,’’ was enacted on

February 25, 2000, to respond to this

crisis. It authorizes funding to stabilize

centers financially and encourage the

enhancement and improvement of

poison education, prevention and

treatment services. It contains

provisions designed to increase the

number of Americans with access to

quality poison control services and

decrease the use of more expensive

emergency medical services, by:

establishing a national toll-free

telephone number with related

nationwide media and advertising

campaigns to ensure access to PCCs for

all Americans; educating the public and

health care providers about poison

prevention and the availability of

poison control resources in local

communities; and establishing a grant

program to improve the financial

stability of PCCs and strengthen

poisoning prevention and treatment

programs and services.

Public Law 106–554 includes an

appropriation of $20 million to fund

activities specified under Public Law

106–174. This Notice addresses the

establishment of the grant program for

poison centers authorized under Section

6(a) of Public Law 106–174 . The law

prohibits use of these grant funds for the

supplantation of other Federal, State,

and local funds and requires

maintenance of effort by the poison

control centers.

The MCHB has sought input from

interested parties as it develops its plan

for a realistic and effective response to

the crisis in the Nation’s PCCs. It has

worked in consultation with the Centers

for Disease Control and Prevention and

Federal Register / Vol. 66, No. 44 / Tuesday, March 6, 2001 / Notices 13549

has met with key stakeholders over the

last year.

Authorization: Poison Control Center

Enhancement and Awareness Act (Pub. L.

106–174).

Purpose

The purpose of this grant program is

to stabilize certified poison control

centers and to encourage the

certification of non-certified centers in

order to improve access to poison

education, prevention and treatment

services. Grants awarded will be used

by PCCs for the purposes of achieving

financial stabilization, assisting noncertified centers to achieve certification,

promoting systems development and

collaboration, and assuring the orderly

transition or development of poison

services by a certified center for rural or

geographically isolated areas.

Eligibility

Eligibility for funding under this grant

program is limited to certified Poison

Control Centers (PCCs). Centers must be

certified by the American Association of

Poison Control Centers or a State with

equivalent standards, as determined by

the Secretary. A waiver of certification

may be granted by the Secretary to noncertified or newly-established PCCs that

apply for a grant if the PCC can

reasonably demonstrate that it will

obtain certification within a three-year

period.

Funding Categories

(1) Financial Stabilization Grants: It is

anticipated that 45–50 grants, ranging

from $60,000 to $1,600,000, will be

awarded in this category to enable

certified PCCs or Poison Control

Systems to achieve financial stability,

strengthen and maintain poison

prevention programs and services, and

strengthen the centers as sources of

treatment information and

recommendations for poisonings.

(2) Certification Grants: It is

anticipated that 10–15 grants, ranging

from $50,000—$200,000, will be

awarded, in order to improve access to

poison prevention services, to noncertified centers or systems which

demonstrate through progress after two

years that they can attain certification

within a three-year period.

(3) Incentive Grants: It is anticipated

that 8–10 competitive grants, at

$125,000, will be awarded to encourage

collaboration and systems development

between centers to strengthen poison

prevention and treatment alternatives.

Applicants may be certified or

uncertified PCCs applying to the

Secretary for a waiver. Centers may

apply in this category in addition to

applying for a Financial Stabilization or

Certification grant. This category carries

a matching requirement of one nonFederal dollar for every two Federal

dollars contributed. Specific guidance

regarding collaboration between PCCs

and the matching requirement is

supplied in the application materials for

this program.

(4) Service Access Grants: It is

anticipated that 2–4 grants will be

awarded, at $50,000 each, for one year

only, to certified centers acting as coapplicants with uncertified PCC’s or

organizations responsible for the

provision of poison control services in

rural or geographically isolated States,

for the purpose of obtaining access to

certified poison control services.

Funding Level/Project Period

Projects will be approved for up to a

three-year period, varying by category.

The total funding level for these grants

is approximately $15 million for the

one-year budget period from August 1,

2001 through July 31. The project period

consists of one or more budget periods,

each generally of one year duration.

Funding for this grant program

beyond FY 2001 is contingent upon the

availability of funds. The initial budget

period is expected to be 12 months,

with subsequent budget periods being

12 months. Continuation of any project

from one budget period to the next is

subject to satisfactory performance,

availability of funds, and program

priorities.

Review Criteria

In general, applications for this grant

program will be reviewed on the basis

of the extent to which they address the

following criteria:

—Completeness and clarity of the

project narrative;

—Practicability and achievability of the

plan to use requested funds;

—Clarity and appropriateness of the

budget and coordinated budget

narrative;

—Strength and adequacy of current and/

or proposed staff;

—Evidence from the responsible State

agency that the applicant is

designated to operate in the State; and

—Clarity and strength of letters of

support or collaboration.

Review criteria vary slightly from one

grant category to another. Further

specific guidance regarding review

criteria is supplied in the application

materials for this program.

Public Health System Reporting

Requirements

This program is subject to the Public

Health System Reporting Requirements

(approved under OMB No. 0937–0195).

Under these requirements, communitybased nongovernmental applicants must

prepare and submit a Public Health

System Impact Statement (PHSIS). The

PHSIS is intended to provide

information to State and local health

officials to keep them apprized of

proposed health services grant

applications submitted by communitybased nongovernmental organizations

within their jurisdictions. Communitybased non-governmental applicants are

required to submit the following

information to the head of the

appropriate State and local health

agencies in the area(s) to be impacted no

later than the Federal application

receipt due date:

(a) A copy of the face page of the

application (SF 424).

(b) A summary of the project (PHSIS),

not to exceed one page, which provides:

(1) A description of the population to

be served.

(2) A summary of the services to be

provided.

(3) A description of the coordination

planned with the appropriate State or

local health agencies.

The project abstract may be used in

lieu of the one-page PHSIS, if the

applicant is required to submit a PHSIS.

Executive Order 12372

This program has been determined to

be a program which is subject to the

provisions of Executive Order 12372

concerning intergovernmental review of

Federal programs by appropriate health

planning agencies, as implemented by

45 CFR Part 100. Executive Order 12372

allows States the option of setting up a

system for reviewing applications from

within their States for assistance under

certain Federal programs. The

application packages to be made

available under this notice will contain

a listing of States which have chosen to

set up such a review system and will

provide a single point of contact (SPOC)

in the States for review. Applicants

(other than federally-recognized Indian

tribal governments) should contact their

State SPOCs as early as possible to alert

them to the prospective applications

and receive any necessary instructions

on the State process. For proposed

projects serving more than one State, the

applicant is advised to contact the SPOC

of each affected State. The due date for

State process recommendations is 60

days after the application deadline for

new and competing awards. The

granting agency does not guarantee to

‘‘accommodate or explain’’ for State

process recommendations it receives

after that date. (See Part 148,

Intergovernmental Review of PHS

13550 Federal Register / Vol. 66, No. 44 / Tuesday, March 6, 2001 / Notices

Programs under Executive Order 12372

and 45 CFR Part 100 for a description

of the review process and requirements).

Dated: February 28, 2001.

Claude Earl Fox,

Administrator.

[FR Doc. 01–5500 Filed 3–5–01; 8:45 am]

BILLING CODE 4160–15–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Human Genome Research

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Human

Genome Research Institute Special Emphasis

Panel.

Date: March 30, 2001.

Time: 12 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: 31 Center Drive, Conference Rm.

B2B32, NHGRI, MD 20892, (Telephone

Conference Call).

Contact Person: Rudy O. Pozzatti, PhD,

Scientific Review Administrator, Office of

Scientific Review, National Human Genome

Research Institute, National Institutes of

Health, Bethesda, MD 20892, 301–402–0838.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.172, Human Genome

Research, National Institutes of Health, HHS)

Dated: February 28, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–5444 Filed 3–5–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: March 9, 2001.

Time: 3 pm to 4 pm.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: David I. Sommers, PhD,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6144, MSC 9606,

Bethesda, MD 20892–9606, 303–443–6470.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientists Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated: February 28, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–5445 Filed 3–5–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Neurological

Disorders and Stroke; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Neurological Disorders and Stroke Special

Emphasis Panel.

Date: March 19, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites, Chevy Chase

Pavilion, 4300 Military Rd., Wisconsin at

Western Avenue, Washington, DC 20015.

Contact Person: Alan L. Willard, PhD,

Scientific Review Administrator, Scientific

Review Branch, NINDS/NIH/DHHS,

Neuroscience Center, 6001 Executive Blvd,

Suite 3208, MSC 9529, Bethesda, MD 20892–

9529, (301) 496–9223.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.853, Clinical Research

Related to Neurological Disorders; 93.854,

Biological Basis Research in the

Neurosciences, National Institutes of Health,

HHS)

February 28, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–5447 Filed 3–5–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Aging; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the